Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up
暂无分享,去创建一个
J. Garber | H. Valdimarsdottir | C. Isaacs | B. Peshkin | M. Schwartz | A. Kinney | M. Wood | W. McKinnon | G. Hooker | K. Graves | M. Similuk | T. Demarco | Rachel Nusbaum | S. McCormick | Morgan N. Similuk | Hannah Segal | Mary K. Interrante | Jessica E. Heinzmann | W. Mckinnon
[1] M. Schwartz,et al. Reply to P.R. Benusiglio et al. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] S. Buys,et al. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Stewart,et al. Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial. , 2016, American journal of public health.
[4] A. Rahm,et al. Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review , 2016, Front. Oncol..
[5] Elizabeth Bourquardez Clark,et al. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study. , 2015, JAMA oncology.
[6] H. Brunner,et al. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling , 2015, Journal of Genetic Counseling.
[7] S. Buys,et al. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. , 2014, Journal of the National Cancer Institute.
[8] J. Garber,et al. Uptake of BRCA1/2 Genetic Testing in a Randomized Trial of Telephone Counseling , 2014, Genetics in Medicine.
[9] Tina Pesaran,et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients , 2014, Genetics in Medicine.
[10] A. Trepanier,et al. Models of Service Delivery for Cancer Genetic Risk Assessment and Counseling , 2014, Journal of Genetic Counseling.
[11] Amanda E Lamb,et al. Acceptability of Telemedicine and Other Cancer Genetic Counseling Models of Service Delivery in Geographically Remote Settings , 2014, Journal of Genetic Counseling.
[12] J. Garber,et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] D. Euhus,et al. The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience , 2013, Genetics in Medicine.
[14] Stephanie A Cohen,et al. Identification of Genetic Counseling Service Delivery Models in Practice: A Report from the NSGC Service Delivery Model Task Force , 2013, Journal of Genetic Counseling.
[15] S. Cummings,et al. NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer , 2013, Journal of Genetic Counseling.
[16] B. Coles,et al. Telegenetics: a systematic review of telemedicine in genetics services , 2012, Genetics in Medicine.
[17] R. Sutphen,et al. Real world experience with cancer genetic counseling via telephone , 2010, Familial Cancer.
[18] H. Valdimarsdottir,et al. BRCA1/2 test results impact risk management attitudes, intentions, and uptake , 2010, Breast Cancer Research and Treatment.
[19] M. Robson,et al. American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. , 2010, Journal of Clinical Oncology.
[20] L. Patrick-Miller,et al. Controversies in Communication of Genetic Risk for Hereditary Breast Cancer , 2009, The breast journal.
[21] H. Valdimarsdottir,et al. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. , 2008, Genetic testing.
[22] G. Koch. Comments on ‘Current issues in non‐inferiority trials’ by Thomas R. Fleming, Statistics in Medicine, DOI: 10.1002/sim.2855 , 2008, Statistics in medicine.
[23] S. Pocock,et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. , 2006, JAMA.
[24] Philippe Ravaud,et al. Quality of reporting of noninferiority and equivalence randomized trials. , 2006, JAMA.
[25] G. Norman,et al. Is it simple or simplistic? , 2003, Medical care.
[26] D. Cella,et al. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. , 2002, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[27] Giovanni Parmigiani,et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] C. Isaacs,et al. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] John E. Ware,et al. SF-36 Health Survey Update , 2000, Spine.
[30] M. Holmes-Rovner,et al. Patient Satisfaction with Health Care Decisions , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.
[31] M. Horowitz,et al. Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.
[32] Chad A. LaGrange,et al. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .
[33] B. Coles,et al. Telegenetics: a systematic review of telemedicine in genetics services. , 2012, Genetics in medicine : official journal of the American College of Medical Genetics.
[34] R. Nussbaum,et al. Genetic/familial high-risk assessment: breast and ovarian. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.
[35] K. Offit,et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Ich Harmonised,et al. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .
[37] John E. Ware,et al. SF-36 physical and mental health summary scales : a user's manual , 1994 .
[38] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .